Abstract
Lung transplantation remains the only treatment for end-stage lung disease with a growing influx of individuals on the waiting list. Availability of suitable lungs for transplant does not parallel this growing trend. The use of lungs from donation after cardiac death (DCD) has been suggested to have equal results to those procured from brain dead donors. Although, concern still exists regarding organ quality and the potential for increased incidence of pulmonary graft dysfunction. We present our experience using lung allografts from Maastricht category III DCD donors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
